In this issue:
A 21-gene assay for node-positive breast cancer recurrence
Adjuvant chemotherapy plus endocrine therapy in early breast cancer patients with a high gene recurrence
Pertuzumab, trastuzumab, and docetaxel for ERBB2-positive breast cancer in Asia
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer
Neoadjuvant pembrolizumab plus chemotherapy for high-risk, early-stage TNBC
Outcomes following 3 or 6 months of adjuvant chemotherapy in high-risk stage II colorectal cancer
Reintroduction vs sequential administration in patients with metastatic colorectal cancer
Korean red ginseng for fatigue in chemotherapy-treated colorectal cancer patients
Molecular profiling and OS in patients with pancreatic cancer
Efficacy vs effectiveness for parenteral cancer therapies
Please login below to download this issue (PDF)